HYPERRAB S/D is a Intramuscular Injection in the Plasma Derivative category. It is labeled and distributed by Grifols Usa, Llc. The primary component is Human Rabies Virus Immune Globulin.
| Product ID | 13533-618_162cf60b-ab94-4762-bdb3-b975001043eb |
| NDC | 13533-618 |
| Product Type | Plasma Derivative |
| Proprietary Name | HYPERRAB S/D |
| Generic Name | Rabies Immune Globulin (human) |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 1996-08-14 |
| Marketing Category | BLA / BLA |
| Application Number | BLA101144 |
| Labeler Name | GRIFOLS USA, LLC |
| Substance Name | HUMAN RABIES VIRUS IMMUNE GLOBULIN |
| Active Ingredient Strength | 150 [iU]/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 1996-08-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA101144 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | ML |
| Marketing Start Date | 1996-08-14 |
| Marketing Category | BLA |
| Application Number | BLA101144 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | ML |
| Marketing Start Date | 2012-11-29 |
| Marketing Category | BLA |
| Application Number | BLA101144 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | ML |
| Marketing Start Date | 2012-11-29 |
| Marketing Category | BLA |
| Application Number | BLA101144 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | ML |
| Marketing Start Date | 1996-08-14 |
| Ingredient | Strength |
|---|---|
| HUMAN RABIES VIRUS IMMUNE GLOBULIN | 150 [iU]/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 13533-318 | HyperRAB | Rabies Immune Globulin (Human) |
| 13533-618 | HYPERRAB | RABIES IMMUNE GLOBULIN (HUMAN) |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() HYPERRAB 78622898 3206857 Live/Registered |
GRIFOLS THERAPEUTICS LLC 2005-05-04 |